Galmed Pharmaceuticals Ltd.
GLMDNASDAQHealthcareBiotechnology
As of Oct 8, 2026 close
- Market cap
- $3.45M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.41$6.35
- Volume (live)
- -
- Avg. volume (3M)
- 26.46K
Galmed Pharmaceuticals (GLMD) Stock Price & Financial Analysis
Galmed Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.42 - $3.63 |
|---|---|
| 52-Week High | $6.35 |
| 52-Week Low | $0.41 |
| Open | $3.61 |
| Volume (last close) | 14.80K |
| Average Volume (3M) | 26.46K |
| 50-Day MA | $4.04 |
|---|---|
| 200-Day MA | $2.49 |
| 1-Year Change | +156.74% |
| Market Cap | 3.45M |
|---|---|
| Shares Outstanding | 952.17K |
| Price to Book (P/B) | 0.27 |
| EV/EBITDA | -0.06 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 8, 2026. Data sources and methodology
Galmed Pharmaceuticals at a Glance
As of the Oct 8, 2026 close, Galmed Pharmaceuticals (GLMD) has a market capitalization of $3.45M.
As of its latest reported balance sheet, it holds $2.88M in cash and securities against $46.00K of debt, a net cash position of $2.84M.
Galmed Pharmaceuticals does not currently pay a dividend.
The share price is up 156.7% over the past year. At $3.62 (the Oct 8, 2026 close) it sits within its 52-week range of $0.41 to $6.35, above its 200-day moving average of $2.49.
Frequently Asked Questions About Galmed Pharmaceuticals
What is the current stock price for GLMD?
As of the Oct 8, 2026 close, GLMD stock trades at $3.62. The 52-week range is $0.41–$6.35, with a day range of $3.42–$3.63.
What is the P/E ratio for GLMD?
The P/E ratio (Price-to-Earnings) for GLMD is shown in the Key Statistics section. This valuation metric helps compare Galmed Pharmaceuticals Ltd. to industry peers.
Does GLMD pay dividends?
Galmed Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GLMD?
Analyst ratings and recommendations for GLMD are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of GLMD?
As of the Oct 8, 2026 close, Galmed Pharmaceuticals's market capitalization is $3.4M, classifying it as a micro-cap company. Galmed Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.